chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discomfort in right deltoid, 24 hours later. Erythema on right deltoid, 4 days later, on 4/28/01. Erythema, induration and maculopapular rash with itching and discomfort on 4/30/01, 7 days later. Examined by doctor and order Motrin and Benadryl. On 5/1/01, mother reports arm is improving.
Hives all over starting on 12/12/2002. Vaccines DTAP, HIB, IPV, and Prevnar administered on 12/10/2002. No other new exposures. Had had DTAP, HIB, and IPV at 2 months, but first time for Prevnar
Information has been received from a nurse concerning a 11-year-11-month- old female patient who was vaccinated with the first dose of GARDASIL IM 0.5ml about 2 weeks ago on appropriately 27-May-2009. The patient had not had her period since she had been vaccinated. The patient had regular periods prior to receiving GARDASIL. It had been approximately 6 weeks since her last period. The patient had sought medical attention, she called the doctor's office. At the time of report, the patient had not recovered. Additional information has been requested.
pt devel flu like sx w/temp around 102 & fussy the morning p/vax;parents took pt to MD who stated it wa a rxn to the shot;pt kept on APAP & pt recovered next day;
My menstrual cycle has dramatically changed since getting the vaccine. What used to be a normal, regular, medium flow 5-7 day period my whole life, has now turned into a heavy & painful mess that lasts 2-3 days. All at once. It continues to be a nightmare of an experience with severe cramping that I have never experienced before. This has happened every month for the last five consecutive months, and the issue has been reported to my doctor.
spent the day in bed after 2nd dose; high fever after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (spent the day in bed after 2nd dose) and PYREXIA (high fever after 2nd dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included Intrauterine contraception since an unknown date. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced BEDRIDDEN (spent the day in bed after 2nd dose) and PYREXIA (high fever after 2nd dose). At the time of the report, BEDRIDDEN (spent the day in bed after 2nd dose) and PYREXIA (high fever after 2nd dose) outcome was unknown.     No concomitant medications were reported. No treatment medications were reported for second dose events.   This case was linked to MOD-2022-445417 (Patient Link).
developed swollen, red, hot  arm, tight neck, 1/3/21 itchy arm, no resp/thrt-referred to allergy
This spontaneous report as received from a medical assistant refers to a 2 year old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 17-SEP-2018, the patient was vaccinated with improperly stored dose of VAQTA ped 0.5 ml vial (dose, frequency and route were not reported) (lot # R009953, expiry date: 12-JUN-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) for 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868:Original Case : 1809USA002868 US-009507513-1902USA009324:Original Case : 1902USA009323 US-009507513-1902USA009325:Original Case : 1902USA009323 US-009507513-1902USA009326:Original Case : 1902USA009323.
sore; all the flu-like symptoms; fever; body aches; headache; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore), INFLUENZA LIKE ILLNESS (all the flu-like symptoms), PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headache) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (sore), INFLUENZA LIKE ILLNESS (all the flu-like symptoms), PYREXIA (fever), MYALGIA (body aches), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea). At the time of the report, PAIN (sore), INFLUENZA LIKE ILLNESS (all the flu-like symptoms), PYREXIA (fever), MYALGIA (body aches), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
seen in ER;>24hrs p/vax w/mild swelling, erythema, induration 2cm x 1cm @ vax site lt thigh;irritability but consolable
Sore throat; Headache; Boyfriend started with fever; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Headache) and PYREXIA (Boyfriend started with fever) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Oct-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Headache) and PYREXIA (Boyfriend started with fever). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Headache) and PYREXIA (Boyfriend started with fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Blood thinners for an unknown indication. No treatment medications were reported.
Child developed a fever 102.2 degrees F & seizure.  Mother took child to ER.
soft pain; This spontaneous case was reported by a physician and describes the occurrence of PAIN (soft pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Hypercholesterolemia.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (soft pain). At the time of the report, PAIN (soft pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant products included medications for high blood pressure and cholesterol.  Treatment information was not provided.
My mouth felt like it had many cuts in it and was reddened.  The inside of my cheeks were swollen and had petechiae on both sides.  My gums felt funny as well.   (I have noticed that my cheeks and tongue still burn from toothpaste and certain things.  I'm not for certain if this was caused by the vaccine.)
a 15-year-old patient received the 1st dose of the Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15-year-old patient received the 1st dose of the Moderna vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination. No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15-year-old patient received the 1st dose of the Moderna vaccine). On 12-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 15-year-old patient received the 1st dose of the Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   There were no side effects after vaccine administration. Patient was aware of the situation. No concomitant medications were reported. No treatment related information was provided.
ITP dx 3/6/06. Admitted hospital, received rhogam. Plt count improved, then decreased. Last count was 28 on 3/26. Also became anemic from rhogam. 05/16/2006-received 8 pages to include DC summary and path report-DOS 3/6/06-C/O bruising easily- DX ITP vs leukemia-f/u with hem oncology at PCMC will be admitted 3/6/06- 06/20/06-5 page office notes received from pediatrician for patient. Note dates 3/2/8/06 indicated that on 3/24/06 platelet count was 23 and HCT was 26. Dr. contacted mother who is sure that the ITP is direct result of immunization patient received prior to his DX of ITP. Hematology at hospital encouraged physician to recheck CBC. on 3/27/06 platelet count and CBC improving. Will recheck hematology if platelet count drops or if he has active bleeding. Note of 3/25/06 mom informed physician that patient is doing well.
Mother reported "bubbling up areas" over MMR and Varicella injection sites, appearing like fluid filled sacks. Mother stated they went away quickly. Took child to MD for assessment and areas had no swelling or redness at that time.
Chills; 100 temperature; Whole body soreness; Left arm severe pain; Left axilla lymph node swelling; Headache; the first dose administered on 19Dec2020 10:00 and the second dose administered on 05Jan2021; the first dose administered on 19Dec2020 10:00 and the second dose administered on 05Jan2021; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch EJ1685) via intramuscular on 19Dec2020 10:00 on left arm at a single dose and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch EL0142) via intramuscular on 05Jan2021 07:45 on left arm at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were reported as none. Prior to vaccination, the patient did not diagnose with COVID 19. The patient was not allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive within 2 weeks of vaccination. The patient experienced chills, 100 temperature, Whole body soreness, left arm sever pain, left axilla lymph node swelling and headache on 05Jan2021 19:00. No treatment received for the adverse event. No covid tests post vaccination. The outcome of the events chills, 100 temperature, Whole body soreness, left arm sever pain, left axilla lymph node swelling and headache was recovering.
No additional adverse event; dose of PROQUAD which was administered past it's expiration date; This spontaneous report was received from other health professional and refers to a patient of unknown age and gender. The patient's medical history, concomitant therapies details, drug reactions or allergies, and concurrent conditions were not reported.  On 05-MAY-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot #T036738, expiration date: 28-APR-2022 (strength, route of administration, and indication were not provided) (Expired product administered) that was reconstituted in a sterile diluent (lot#U011647, expiration date: 28-AUG-2023). No additional adverse event or product quality complaint were reported.
Patient diagnosed with Varicella 1/22/07. Had vaccine 9/8/04. Follow up information: VARIVAX given 10/20/04.
Warm, red, swollen and sore injection site lasting longer than 48 hours. Lymph nodes swollen under treated arm
Patient said that the next day she felt nauseous, lost her energy, her muscles would not move, she could not lift her arm, or talk. They called an ambulance and she was taken to the hospital. They ruled out other causes and the ER doctor told her it was from the flu shot.  She had nausea for several days and abdominal pain. Prior to the shot she went to have blood work done to check her liver enzymes. She is following up with her pcp.
LETHARGIC (FATIGUED,VERY TIRED,UNABLE TO GET OUT OF BED); WINDED FROM WALKING AND RUNNING; PERIOD DELAYED BY 2 WEEKS; This spontaneous report received from a patient concerned a 42 year old female. The patient's weight was 130 pounds, and height was 66 inches. The patient's concurrent conditions included social drinker, non smoker, and copper iud, and other pre-existing medical conditions included the patient had no known allergies and had no drug abuse or illicit drug usage. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced period delayed by 2 weeks. On 26-APR-2021, the subject experienced lethargic (fatigued, very tired, unable to get out of bed). On 26-APR-2021, the subject experienced winded from walking and running. The action taken with covid-19 vaccine  was not applicable. The patient recovered from period delayed by 2 weeks, had not recovered from lethargic (fatigued,very tired,unable to get out of bed), and the outcome of winded from walking and running was not reported. This report was non-serious. This case, from the same reporter is linked to 20210537334.
Pt has developed a circular rash to injection site that is spreading. She has also developed tingling and numbness to left extremity that is worsening.
nausea, vomiting, diarrhea, palpitations and SOB. 911 was called to facility per doctors request patient transported to Hospital.
This spontaneous prospective pregnancy case reported by a consumer, describes the occurrence of maternal exposure during pregnancy (pregnant patient received 2 vaccines) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was Jul 23, 2021. On Feb 12, 2021, patient experienced maternal exposure during pregnancy (pregnant patient received 2 vaccines). On Mar 12, 2021, maternal exposure during pregnancy (pregnant patient received 2 vaccines) resolved. Diagnostic results: On an unknown date: Pregnancy test: Positive. On an unknown date, Ultrasound scan: Normal. No concomitant medication or treatment information reported. Patient reported an ultrasound was completed on an unknown date and resulted in normal findings. The patient's pregnancy test was positive on Nov 10, 2020.
Extreme muscle cramping, sore arm, fainted, unable to walk or stand, removed by ambulance to hospital, kept overnight and released the following afternoon.
Woke up 2 days later with pain and swelling under my eyes and in my chin. These are places that I have had dermal filler. I started steroids immediately, swelling went down after 2 days.
Face being red and hot; Stiff neck; Dizziness; Weakness; Hardly able to move; Loss of appetite; Diarrhea; Couldn't think right; Severe headache; Fatigue; Chills; Body aches and muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness) and MOBILITY DECREASED (Hardly able to move) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac) since an unknown date.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness), MOBILITY DECREASED (Hardly able to move), DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), THINKING ABNORMAL (Couldn't think right), HEADACHE (Severe headache), FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Body aches and muscle aches). On 18-Jan-2021, FLUSHING (Face being red and hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), DIZZINESS (Dizziness), ASTHENIA (Weakness), MOBILITY DECREASED (Hardly able to move), DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), THINKING ABNORMAL (Couldn't think right), HEADACHE (Severe headache), FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Body aches and muscle aches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment of the events included Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow up report received on 13APR2021 included the patient's second dose information for the suspect drug.
pt recvd vax 19JUN95 & 20JUN95 pt exp itching all over & had pimple like spots all over forehead;pt was not vaxed w/2nd dose;no further details were provided;
Summary:  rash, hair loss (general thinning and dime-sized distinct patch lost at front crown) extreme fatigue, hair loss and fatigue lasting over 3 months; fever, chills, body aches worse than any patient had experienced in over 10 years; reaction to shot 2 triggered flare in inflammatory bowel or endometriosis pain, inflammation around IUD requiring removal, ovarian cysts and pain.  Patient recorded menstrual cycle days and received booster on day 3 of menstrual cycle (based on studies showing hormonal role in vaccine seroconversion).  Patient was mandated to receive booster shot or be fired from her employment (graduate student instructor) and be unable to complete her doctoral degree (registration and enrollment hold and suspension).  Patient contacted primary care and OBGYN providers, COVID-19 advisory committee, and disability compliance office with concerns about side effects from second shot (previously reported).  Case was escalated to the Medical Director.  Dr. stated that the Office had removed the normal medical exception option for the COVID-19 vaccination and only a very narrow list of CDC reactions could quality for exemption.  Due to the failure of vaccine trials to adequately represent and record side effects common in women and people with auto-immune risk, doctors initially did not believe patient.  Patient suspected COVID-19 infection in March of 2020.  Patient requested nucleocapsid test to confirm seropositivity, but was denied and could not self-order test at any location (patient also contacted laboratory facilities).  Please see report of reaction to 2nd Pfizer dose in E report number 780379.  Given the threat to patient's livelihood and education, patient received Moderna booster after medical exemption requests were denied.  Patient developed a fever (normal is 97.6) that slowly rose until patient took ibuprofen at around 101.  Patient developed chills, body aches, head ache, restlessness, extreme pressure and pain in fingernails (like they were going to pop off), followed by extreme fatigue for over 3 months, left armpit lymph node swelling for over 2 weeks, rash on neck and under armpit that was unusual to patient, general hair thinning and loss of dime-sized patch of hair.
Have her dental work done; Sore arm; Achy; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Achy) and DENTAL CARE (Have her dental work done) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 03M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PAIN (Achy). On an unknown date, the patient experienced DENTAL CARE (Have her dental work done). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 21-Mar-2021, PAIN IN EXTREMITY (Sore arm) and PAIN (Achy) had resolved. At the time of the report, DENTAL CARE (Have her dental work done) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Received a call from above employee stating that she received Flu shot yesterday 11/4/02 and towards the evening, noticed itchy-like reddish spots all over her body. Plans to contact MD about this reactions today.
redness around the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th June 2022 13:40, the patient received Shingrix. In June 2022, less than a week after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-Jun-2022 Reporter's Comments: The patient self-reported this case. The patients doctor's office was closed hence he/she just wanted to see if it was normal to have redness around the injection site. Additional Supportive Information: The follow-up would not be possible as no contact details were available.
The injection itself was very painful, nothing like the previous two Covid vaccine injections I had received. My arm was sore immediately thereafter and it felt like the injection had been put into the incorrect location. I didn't want to say anything at the time because the pharmacist herself did the injection and I just figured she knew what she was doing. for several days afterward my shoulder was sore and certain movements were painful but I wasn't completely sure it wasn't A normal consequence from the injection. The pain and soreness came and went in varying degrees over the next couple of weeks but I ended up going to an orthopedist to get my shoulder looked at. They examined me and did an x-ray but concluded it was probably a Rotator cuff injury and gave me some exercises to do along with an anti-inflammatory. These didn't really seem to help. Most of my range of motion is OK but certain movements are extremely painful and at night, I frequently have trouble sleeping because of pain and soreness in that muscle.
Diffuse myalgias, fatigue, nausea, sweating for approximately 36 hours, with onset approx. 5-10 hours after receiving vaccines. Rash developed 8/17/09.